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Abstract 
Background: Differentiating between septic and aseptic joint prosthesis may be challenging, since no single 
test is able to confirm or rule out infection. The choice and interpretation of the panel of tests performed in 
any case often relies on empirical evaluation and poorly validated scores. The "Combined Diagnostic Tool 
(CDT)" App, a smartphone application for iOS, was developed to allow to automatically calculate the 
probability of having a of periprosthetic joint infection, on the basis of the relative sensitivity and specificity of 
the positive and negative diagnostic tests performed in any given patient. 
Objective: The aim of the present study was to apply the CDT software to investigate the ability of the tests 
routinely performed in three high-volume European centers to diagnose a periprosthetic infection.  
Methods: This three-center retrospective study included 120 consecutive patients undergoing total hip or 
knee revision, and included 65 infected patients (Group A) and 55 patients without infection (Group B). The 
following parameters were evaluated: number and type of positive and negative diagnostic tests performed 
pre-, intra- and post-operatively and resultant probability calculated by the CDT App of having a 
peri-prosthetic joint infection, based on pre-, intra- and post-operative combined tests. 
Results: Serological tests were the most common performed, with an average 2.7 tests per patient for 
Group A and 2.2 for Group B, followed by joint aspiration (0.9 and 0.8 tests per patient, respectively) and 
imaging techniques (0.5 and 0.2 test per patient). Mean CDT App calculated probability of having an infection 
based on pre-operative tests was 79.4% for patients in Group A and 35.7 in Group B. Twenty-nine patients in 
Group A had > 10% chance of not having an infection, and 29 of Group B had > 10% chance of having an 
infection. 
Conclusion: This is the first retrospective study focused on investigating the number and type of tests 
commonly performed prior to joint revision surgery and aimed at evaluating their combined ability to 
diagnose a peri-prosthetic infection. CDT App allowed us to demonstrate that, on average, the routine 
combination of commonly used tests is unable to diagnose pre-operatively a peri-prosthetic infection with a 
probability higher than 90%. 
Key words: Periprosthetic Joint Infections; PJI; Diagnosis; Smartphone Application; Combined Diagnostic Tool. 
Introduction 
Joint arthroplasty is one of the most common 
procedures in orthopedic surgery, and the number of 
both hip and knee arthroplasty procedures are 
expected to substantially grow over the next few 
years 1. Despite the advancements in implant design, 
fixation and infection control, prosthetic failure is still 
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a relatively common occurrence, with a reported 
prevalence of approximately 4% 2. Periprosthetic joint 
infection (PJI) is amongst the main reasons for implant 
failure, and often results in prolonged and expensive 
treatment 2,3.  
Although PJI can be clinically evident in some 
cases, in many others the diagnosis can be extremely 
challenging; in fact clinical presentation of PJI may 
only be characterized by unspecific pain at the 
operated joint and the differential diagnosis with 
other common reasons for implant failure, like aseptic 
loosening or neuropathic pain can be difficult, since 
no single diagnostic test is able to provide 100% 
sensitivity and specificity, thus the evaluation of a 
combination of tests becomes often necessary. Dosing 
of various serum and synovial markers, use of 
different imaging techniques, microbiological and 
histological analysis are then variably associated to 
refine the diagnosis, unfortunately often with 
conflicting results, whose interpretation is confusing 
and still generally based on an empirical 
evaluation 4-8. In fact, even the most recently 
published scores to define a PJI have not been 
clinically validated and rely on the “experts 
opinion” 9, while the proposed diagnostic protocols 
cannot avoid ending without the statement that an 
infection is “likely” or “unlikely”, without further 
specification of how much the likelihood is in a 
specific case 10. Unfortunately, however, the surgeon 
is requested to decide the most appropriate treatment 
strategy based on this likelihood. 
This study utilizes a previously validated 
algorithm based on the known sensitivity and 
specificity of the performed tests11, to better calculate 
the relative probability of a joint prosthesis to be 
infected or not. Recently, we included this algorithm 
into a smartphone application, “Combined Diagnostic 
Tool” or “CDT App”, to further investigate its 
potential use as a readily accessible point of care and 
decision-making tool.  
Objectives 
Aim of the present study is to retrospectively 
evaluate through the CDT App the relative ability of 
the tests commonly performed in three high volume 
surgical departments in Europe to diagnose PJI. The 
secondary aim is to evaluate the number, type and 
results of the diagnostic tests routinely performed to 
diagnose a peri-prosthetic joint infection in three high 
volume centers. 
Methods 
Combined Diagnostic Tool App 
The Combined Diagnostic Tool is an application 
developed for iOS working smartphones and tablets, 
based on a previously validated algorithm that 
combines the output of different diagnostic tests. The 
rationale, development and validation of the 
algorithm has been previously reported 11. Briefly, 
based on the sensitivity and specificity of each test, it 
is possible to calculate the relative proportion of True 
Negatives (TN), False Negatives (FN), True Positives 
(TP) and False Positives (FP) for each test. According 
to the formula:  
NTI = TN / FN = specificity of the negative test / 1 - 
sensitivity of the negative test 
We can then calculate the “Negative Test Index” 
(NTI), that indicates the relative chance that a subject, 
seen as negative by a given test, has of being truly 
negative, compared to falsely positive. The higher the 
value of NTI, the higher the chance that test correctly 
indicated that subject as NOT having the disease. 
Similarly, we can calculate the Positive Test 
Index (PTI) according to 
PTI = TP / FP = sensitivity of the positive test / 1 - 
specificity of the positive test 
PTI indicates the relative chance that the subject 
is a TP compared to a FP. The higher the value of PTI, 
the higher the chance that test correctly indicated that 
subject as HAVING the disease. 
Assuming that we have n independent tests, 
performed on a given subject, the combined chance of 
positive or negative results to be true is, respectively: 
PTIn = (TPa * TPb * TPn)/(FPa * FPb * FPn)  
and  
NTIn = (TNa * TNb * TNn)/(FNa * FNb * FNn) 
The ratio between PTI and NTI will then be 
indicated as the Combined Tests Index (CTI): 
CTI = PTIn / NTIn 
CTI indicates how many times the output of the 
combined positive tests is, compared to the output of 
the combined negative tests. The higher its value, the 
higher the chance the positive results are “more true” 
and that the subject HAS the disease and vice versa. 
The “Combined Diagnostic Tool” App, 
specifically designed for the combined diagnosis of 
peri-prosthetic joint infections, works with reference 
values of sensitivity and specificity of the most 
common diagnostic tests as reported in the literature 
and in the App itself. Based on these reference values 
and on the results of different tests in a given subject, 
the software is able to automatically calculate the NTI, 
PTI and CTI of any tests combination. CTI values are 
then expressed as relative probability of having or not 
the infection both as a proportion and as a percentage: 
50% change or 1 : 1 means equal chance of being 
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infected or not, 3 : 1 or 75% means that a patient has 
75% chance of being infected compared to 25% of 
being not, etc.  
In addition the App offers the possibility to 
update the values of sensitivity and specificity of each 
test as they become updated in the literature, and to 
include new tests that may become available for 
clinical use. Moreover, it allows to simulate what 
could be the relative contribution to the final 
diagnosis of any further test that the physician would 
like to perform in a given subject. The reference values 
used in this study are those listed in our previous 
paper 11 and given in the Appendices. 
Study population and pre-operative analysis  
This study was undertaken across three-centers, 
and included the Istituto Ortopedico IRCCS Galeazzi, 
Milano, Italy; Istituto Clinico Humanitas, Rozzano, 
Italy; and Sheffield Teaching Hospital, Sheffield, UK. 
Given the retrospective nature of the study and the 
post-hoc analysis performed on the data, an informed 
consent from the patients for study participation was 
not required, according to the policy of the respective 
participating centers.  
A total of 120 consecutive patients, treated 
during 2011-2012 with total hip or knee revision at a 
minimum of 12 months follow-up, were included in 
the study. Patients were classified in two groups, 
according to the surgical treatment received, as Group 
A (treated as infected: N=65) and Group B (patients 
treated as not-infected: N=55) (Table 1). 
 
Table 1. Pre-operative data of the population under study. 
 Group I - Patients treated 
as infected (N=65) 
Group NI - Patients treated 
as not infected (N=55) 
Sex (Male / Female) 28 / 37  25 / 30 
Age (Mean +– S.D.) 64.3 +- 15.8 67.2 +-16.0 
Joint (Hip / Knee) 31 / 34 28 / 27 
 
 
For each patient, the type, number and result 
(positive or negative) of the diagnostic tests 
performed pre- and intra-operatively to confirm or to 
exclude a peri-prosthetic infection were recorded and 
analyzed with the CDT application, in order to obtain 
the pre-operative and post-operative calculated 
chance of being or not infected and to compare this 
with the treatment finally performed in each patient. 
Pre-operative tests included serological testing, 
joint aspiration and imaging techniques (radiology, 
sonography and bone scans), depending upon each 
center’s protocols.  
Serological testing was considered positive 
following each center’s cut off values.  
Joint aspiration was considered positive if the 
WBC count in synovial fluid was above 3000 cells/µL 
or if cultural examination found microorganisms.  
Intra-operative tests included histological and 
microbiological sampling. In particular, frozen and 
permanent histological analysis was performed in all 
participating centers on at least three samples 
obtained from the pseudocapsule, the membrane 
around the prosthesis or tissue suspected for infection 
(i.e. fibrotic or necrotic reactions). The samples used 
for frozen-section analysis were immediately frozen 
in carbon dioxide; 4mm section were cut and stained 
with standard hematoxylin eosin. Most cellular areas 
in each sample were chosen, and the number of 
neutrophils in at least ten high power field, HPF 
(x400) was counted. The presence of infection was 
defined according to Feldman criterion 12, i.e. the 
presence of at least five neutrophils per HPF. Results 
obtained from frozen-section histology were then 
computed with CDT app, thus obtaining an 
intra-operative CTI. 
Permanent histological analysis and cultural 
examinations were performed according to each 
Institution protocol and surgeon preferences. Samples 
for histological analysis were collected in the same 
way already described for frozen-sections. If both 
frozen section and permanent histological analysis 
were performed on the same patient, each sample was 
divided in two parts, one for each type of 
examination. Samples for permanent histological 
analysis were immediately fixed in formalin and 
embedded in paraffin before the hematoxylin eosin 
staining. Criteria used for define infection were the 
same described above for frozen samples. 
Microbiological analysis required 4 to 6 samples 
from different sites of periprosthetic tissue. Liquid 
samples were aspirated using a sterile syringe, and 
immediately inoculated into an automated culture 
system, and underwent 7 days of incubation. Positive 
samples were subsequently cultured in anaerobic and 
aerobic agar media. Solid tissue samples from 
periprosthetic tissue were placed into a sterile case, 
and subsequently cultured in anaerobic and aerobic 
agar media and in thyoglicolate broth enriched with 
vitamin K and hemin. After an incubation time of 10 
days positive cultures were sent for organism 
identification and sensitivity testing.  
Results from histology and cultural examination 
were computed in the CDT app, thus giving the final 
CTI for each patient included in the study. 
Statistical analysis 
The following parameters were evaluated per 
patient; number of tests performed pre-operatively 
per patient; number of positive and negative tests per 
patient; CDT App calculated chance of having a PJI.  
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Statistical analysis was performed using Stata 
software (version 11.0, StataCorp, Texas, USA). 
Percentage of positive tests in both groups were 
compared using Chi-square test, with a p-value of 
<0.05 was deemed statistically significant.  
Results 
Serological tests were the most commonly 
performed, with an average 2.7 tests per patient for 
Group A and 2.2 for Group B, followed by joint 
aspiration (0.9 and 0.8 tests per patient, respectively) 
and imaging techniques (0.5 and 0.2 test per patient). 
Serum markers were positive in 59.7% in Group A 
and 22.8% in Group B (p<0.01).  
Joint aspiration were found positive for PJI in 
65.6% in Group A and 24.4% in Group B (p<0.01). 
Pre-operatory imaging was suggestive for infection in 
74.2% in Group A and 22.2% in Group B (p<0.001) 
(Table 2 and Table 3). 
 
Table 2. Type, number and results (positive or negative) tests 
performed in patients eventually treated as infected (Group A, n 
=65) 
 Positive tests 
(%) 
Negative 
Tests (%) 
Total Average Tests 
per Patients 
Serum 
Markers 
105 (59.7) 71 (40.3) 176 (46.3) 2.7 
Joint 
Aspiration 
40 (65.6) 21 (34.4) 61 (16.1) 0.9 
Imaging 
Techniques 
23 (74.2) 8 (25.8) 31 (8.2) 0.5 
Frozen 
Sections 
10 (90.9) 1 (9.1) 11 (2.9) 0.2 
Intra-op 
Cultures 
57 (63.3) 33 (36.7) 90 (2.7) 1.4 
Histology 11 (100) 0 (0) 11 (2.9) 0.2 
Total Exams 243 (64.7) 134 (35.3) 380 (100) 5.8 
 
Table 3. Type, number and results (positive or negative) tests 
performed in patients eventually treated as non-infected (Group B, 
n = 55) 
 Positive tests 
(%) 
Negative 
Tests (%) 
Total Average Tests 
per Patients 
Serum 
Markers 
28 (22.8) 95 (77.2) 123 (45.7) 2.2 
Joint 
Aspiration 
11 (24.4) 34 (75.6) 45 (17.4) 0.8 
Imaging 
Techniques 
2 (22.2) 7 (77.8) 9 (3.5) 0.2 
Frozen 
Sections 
0 (0) 1 (100) 1 (0.4) 0.02 
Intra-op 
Cultures 
8 (10) 72 (90) 80 (30.9) 1.5 
Histology 0 (0) 1 (100) 1 (0.4) 0.02 
Total Exams 49 (18.9) 210 (81.1) 259 (100) 4.7 
 
On the basis of the pre-operative tests, the mean 
chance of having an infection, as calculated with the 
CDT App, was 79.4% ± 30.3% (range 0.2%-99.99%) for 
patients in Group A and 35.7 ± 36.0 (range 
0.68%-99.86%) in Group B. Twenty-nine patients in 
Group A had > 10% chance of being NOT infected 
and 29 of Group B had > 10% chance of having an 
infection (see Table 4).  
 
Table 4. Mean +- SD and minimum and maximum chance (%) of 
having a peri-prosthetic joint infection, calculated with the CDT 
App on the basis of pre-, intra- and post-operative findings. Group 
NI: patients treated as not infected; Group I: patients treated as 
infected.  
 Group NI Group I 
Pre-operative 35.7 +- 36.0 (0.68 – 99.86) 79.4 +- 30.3 (0.2 – 99.99) 
Intra-operative 35.8 +- 35.9 (0.68 – 99.86) 77.5 +- 32.8 (0.2 – 99.99) 
Post-operative 22.9 +- 29.6 (0.05 – 97.82) 82.6 +- 33.7 (0.02 – 99.99) 
 
 
Intra-operative histology (frozen sections) had 
been performed in only 22 patients. When 
implemented in the calculation of each patients 
probability of being infected, in combination with 
pre-operative findings, resulted in a chance of being 
infected of 95.7% ± 5.1% (min: 85.4%; max: 99.96%) for 
patients in Group A, and 10.2% ± 13.3% (min: 10.0%; 
max: 18.6%) in Group B.  
A total of 170 intra-operative cultures were 
performed, 90 in Group A patients (mean 1.4 per 
patient) and 80 in Group B (mean 1.5 per patient). In 
Group A 63.3% of intra-operative cultures were 
positive for the presence of microorganisms, while in 
Group B 10% yielded a positive result (p<0.0001). 
Eleven patients in Group A underwent tissue 
sampling for histological examination. All the 
samples obtained in this group confirmed the 
diagnosis of infection according to Feldman criteria.  
Both histological findings and cultural data were 
implemented in each patient’s individual score 
calculation, which lead to a post-operative chance of 
having a PJI of 90.0% ± 25.4% (min: 5.3%; max: 
99.99%) for patients in Group A and 25.4% ± 24.0% 
(min: 0.05%; max: 69.0%) in Group B. 
Discussion 
This is to our knowledge the first multicenter 
study reporting on the number, type and results of the 
diagnostic tests routinely performed to diagnose a 
peri-prosthetic joint infection in patients undergoing 
revision surgery. Moreover, this is the first report on 
the application of a previously validated algorithm to 
the calculation of the relative chance of being infected, 
based on a combination of positive and negative tests, 
as often occurs in the clinical setting. Furthermore, 
this study shows how said algorithm can be 
implemented and made readily available to 
physicians as a smartphone application. 
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Figure 1. A. The “Combined Diagnostic Tool” or CDT App is designed for iOS devices (iPhone, Apple, California); B. and C. Screenshots showing, 
respectively, the App at baseline, with the reference bar set at 1:1 or 50% or after a combination of tests providing a chance of peri-prosthetic infection of 
73 : 1 or 98.65%. 
 
Concerning the type and number of tests, our 
data shows how, on average, each patient undergoing 
revision surgery undergoes more than five different 
examinations; in this regard, those more often 
investigated are serum markers, with a mean of 2.7 
tests per patient in Group A and 2.2 in Group B. This 
appears to be in line with many recommendations, 
that report C-reactive protein (CRP) and 
erytrosedimentation rate (ESR) as a mandatory part of 
any protocol to rule out or to confirm a PJI 10,13,14. The 
second most executed test was joint aspiration for 
synovial fluid analysis, with a mean of 0.9 tests per 
patient in Group A and 0.8 in Group B. In fact, various 
studies evaluated the WBC in synovial fluid in 
patients with suspected PJI, showing consistent 
elevation of WBC in infected subjects when compared 
with non-infected cases 13,15,16. Elevated serum CRP 
and ESR and elevated WBC in synovial fluid have 
also been recently listed as useful criteria to define the 
presence of a PJI, however, neither are 
pathognomonic and hence it is recommended that all 
are performed and evaluated in light of the individual 
patients other findings 14.  
The aim of this study was to evaluate the relative 
ability of the tests commonly performed in three high 
volume surgical departments in Europe to diagnose 
PJI through the CDT App. The App allowed us to 
show that, on average, the pre-operative 
investigations are unable to confirm or to exclude the 
diagnosis of infection with a probability higher than 
90%. Indeed, while our data shows how each 
preoperative test performed is more frequently 
positive in patients treated as infected, the CTI 
calculation highlight the fact that the probability of 
actually having a PJI is only the 79.4% in Group A, 
compared with the 35.7% in Group B, with an 
extremely high variability. In this context, it must be 
noted that this diagnostic uncertainty is present every 
time we interpret examination results in clinical 
practice, and the CDT data offers just a mathematical 
quantification of that uncertainty.  
When dealing with preoperative diagnostics, the 
routine use of CDT app can be extremely helpful for 
two main reasons. First, knowing the probability that 
a given patient actually has a PJI after performing the 
first line examination, and considering the implication 
that this diagnosis has on the treatment, can help the 
surgeon in deciding if further examination are needed 
to increase the accuracy of the diagnosis.  
Second, the app can be used to simulate and 
quantify the impact that a given test has on the overall 
probability of the presence of a PJI. For example, we 
can hypothesize a situation in which, after a positive 
ESR and CRP, and a joint aspiration with a normal 
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WBC count, using CDT app we found a probability of 
having a PJI of 62%. If we consider this probability too 
low to decide for treatment, we might wonder what 
would be the impact of performing a leukocyte bone 
scan on the diagnostic accuracy. Using CDT app we 
could calculate and quantify this data before 
performing the examination, thus basing decision to 
perform the test or not on accurate statistical 
information. This approach can have also a significant 
economical implication, since knowing the impact of a 
given test on the diagnostic accuracy in a given 
patient, could help in deciding whether performing 
an additional test is cost effective.  
These considerations can be extended to the 
intra-operative investigations. Using the CDT App to 
calculate the impact that either frozen section and 
definitive histological examination have on the 
patient can help the surgeon in surgical planning, 
especially when frozen section is needed. According 
to our data, in Group A patients the percentage of 
frozen section that yielded a positive result was 90.9% 
(10/11), while the single patient in Group B who 
underwent frozen section analysis had a negative 
result.  
Several different histological criteria for defining 
infection are reported in literature. In some cases 
more comprehensive criteria were used, such as 1-cell 
per HPF or even the presence of lymphocytes or 
plasma cells 17,18, while other studies reported more 
restrictive criteria, such as >5 neutrophils in at least 5 
HPF 12,19. The former criteria favor sensitivity over 
specificity, while the latter favor specificity over 
sensitivity. The choice between comprehensive or 
restrictive criteria depends on the role frozen section 
has in the diagnostic process, whether used as a 
screening tool or as a confirmatory test. In the 
ultimate analysis, the efficacy of the chosen criteria 
depends on the pre-test probability of having the 
disease, with stringent criteria more efficacy in a 
situation of high pre-tests probability. Since the 
pre-test probability is easy calculated with CDT app, 
selecting patients who truly benefits from frozen 
section analysis become simpler and more precise.  
One of the main finding of the present study is 
showing how a complex algorithm can be easily 
implemented in clinical practice. Regarding this point, 
older reports about routine application of diagnostic 
software in clinical practice identified the time 
required for data input as one of the main limiting 
factors20,21. Moreover, in a pivotal review on 
algorithm-based diagnostic supports, Kawamoto 
identified the availability at the time and location of 
decision making and the integration in routine 
workflow two key features needed for success of these 
systems 22. In recent years technological advances in 
smartphones have led to a widespread use of portable 
devices with high computing power. Their 
availability and easy to use interface makes them the 
perfect tool to facilitate the application of complex 
algorithms in clinical practice. In this context the 
development of a smartphone application fits 
perfectly. Indeed, the main advantages of the CDT 
app are its portability, quickness and applicability at 
the point of care.  
Another important advantage of the CDT app is 
that the sensitivity and specificity data used in the 
algorithm for each test can be easily updated with the 
most recent publications found in the literature. This 
allows the tool to be always up to date.  
The present study has limitations. Reference data 
for sensitivity and specificity used in CDT app 
algorithm are taken from literature studies. This 
introduces several bias; (a) population in which a give 
test was studied may differ from population in which 
the CDT app is used, (b) frozen section analysis, 
different diagnostic criteria and reference normal 
value for a given test differs in each laboratory, (c) the 
type of tests used in the participating centers and 
available during years 2011-2012, (d) current novel 
biomarkers and synovial fluid tests, such as 
alpha-defensin or esterase, are more often performed 
and were not included in this analysis, and (e) we 
applied the CDT app to two cohorts of patients 
treated respectively as infected or non-infected on the 
basis of a selection of tests decided by the surgeons, 
whilst the choice of the tests and their interpretation 
could have been different in each hospitals. 
Prospective, well designed studies are needed to 
further evaluate the role of the CDT app as an aid to 
diagnose PJI.  
Conclusion 
In conclusion, with this study we have shown 
that PJI diagnosis is the result of a combination of 
tests; the CDT app, a smartphone application 
designed to aid the surgeon in PJI diagnosis by 
calculating the overall probability of presence of PJI, 
when applied retrospectively did reveal that, on 
average, patients treated as infected still had 
approximately 20% chance of being not-infected and 
vice versa. The app, updated on a regular basis with 
new data and tests, may be extremely helpful in 
designing individual diagnostic approaches and in 
planning further examinations. Moreover, 
accessibility and ease of use of CDT app make it the 
ideal tool for point of care application of complex 
algorithm.  
Supplementary Material  
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